Progressive Multifocal Leukoencephalopathy after Ibrutinib Therapy for Chronic Lymphocytic Leukemia

Progressive multifocal leukoencephalopathy (PML) is a devastating neurological disease observed nearly exclusively in immunocompromised patients. Recently, the introduction of monoclonal antibodies significantly inhibiting the immune system such as rituximab has led to an increase in PML cases. Alth...

Descripción completa

Detalles Bibliográficos
Autores principales: Lutz, Mathias, Schulze, Arik B., Rebber, Elisabeth, Wiebe, Stefanie, Zoubi, Tarek, Grauer, Oliver M., Keßler, Torsten, Kerkhoff, Andrea, Lenz, Georg, Berdel, Wolfgang E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398396/
https://www.ncbi.nlm.nih.gov/pubmed/27456945
http://dx.doi.org/10.4143/crt.2016.110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398396/
https://www.ncbi.nlm.nih.gov/pubmed/27456945
http://dx.doi.org/10.4143/crt.2016.110

Ejemplares similares